IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Por um escritor misterioso
Descrição
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances
IJMS, Free Full-Text
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
Frontiers A neutralizing bispecific single-chain antibody against SARS-CoV -2 Omicron variant produced based on CR3022
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
de
por adulto (o preço varia de acordo com o tamanho do grupo)
format(webp))
